Kalaris Therapeutics, Inc. (KLRS) Insider Trading
Sector: Biotechnology · Market Cap: $104M · 0 insider purchases in the last 7 days
No open market insider purchases at Kalaris Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track KLRS on your watchlist.
Start for FreeAbout Kalaris Therapeutics, Inc. Insider Trading
1 insider at Kalaris Therapeutics, Inc. (KLRS) has purchased stock in the past 90 days, totaling $1.2M across 1 transaction (244,300 shares).
The most recent purchase was by Director AKKARAJU SRINIVAS on May 20, 2026 — a $1.2M buy of 244,300 shares at $4.83, bringing their total holdings to 2,224,147 shares.
This level of insider buying appears elevated compared to KLRS's typical activity — there were 1 purchase in the prior nine months.
KLRS is in the Biotechnology sector within the Biotechnology industry with a market cap of $104M.
Track KLRS insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.